These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 6589041)
1. Augmentation of human natural killer cell activity by cyclophosphamide in vitro. Sharma B; Vaziri ND Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041 [TBL] [Abstract][Full Text] [Related]
2. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
3. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
4. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F; Peri G; Villa A; Mantovani A J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624 [TBL] [Abstract][Full Text] [Related]
5. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics. Bloom ET; Babbitt JT; Kawakami K J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665 [TBL] [Abstract][Full Text] [Related]
6. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission. Inada M; Okawa H; Suzuki M; Yata J Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376 [TBL] [Abstract][Full Text] [Related]
7. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells. Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860 [TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity. Edwards BS; Hawkins MJ; Borden EC Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292 [TBL] [Abstract][Full Text] [Related]
10. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity. Luger TA; Uchida A; Köck A; Colot M; Micksche M J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831 [TBL] [Abstract][Full Text] [Related]
11. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J. Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813 [TBL] [Abstract][Full Text] [Related]
12. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing. Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107 [TBL] [Abstract][Full Text] [Related]
13. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay. Uchida A; Yanagawa E J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485 [TBL] [Abstract][Full Text] [Related]
14. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. Lotzová E; Savary CA; Herberman RB J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084 [TBL] [Abstract][Full Text] [Related]
15. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
16. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
17. [Regulation of the natural killer activity of lymphocytes from healthy donors and patients with chronic lympholeukemia through the interaction of T- and non-T cells]. Khonina NA; Shubinskiĭ GZ; Lozovoĭ VP Biull Eksp Biol Med; 1987 Mar; 103(3):321-3. PubMed ID: 3493815 [TBL] [Abstract][Full Text] [Related]
19. Investigation of porcine natural-killer cell activity with reference to African swine-fever virus infection. Norley SG; Wardley RC Immunology; 1983 Aug; 49(4):593-7. PubMed ID: 6575959 [TBL] [Abstract][Full Text] [Related]
20. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]